Inmed Pharmaceuticals Inc (INM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,537 | -7,948 | -7,609 | -5,611 | -3,510 |
| Depreciation Amortization | 55 | 202 | 149 | 98 | 49 |
| Accounts receivable | 95 | -219 | -107 | -19 | 73 |
| Other Working Capital | 94 | -566 | -302 | -444 | 410 |
| Other Operating Activity | 120 | 1,247 | 1,245 | 1,007 | 723 |
| Operating Cash Flow | $-2,174 | $-7,283 | $-6,625 | $-4,969 | $-2,256 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -160 | -128 | N/A | N/A |
| Net Acquisitions | N/A | -500 | -500 | -500 | N/A |
| Other Investing Activity | 0 | -2 | 0 | 0 | 0 |
| Investing Cash Flow | $N/A | $-662 | $-628 | $-500 | $0 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 10,681 | 10,681 | 10,744 | 6,000 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -571 |
| Financing Cash Flow | $N/A | $10,681 | $10,681 | $10,744 | $5,429 |
| Beginning Cash Position | 8,913 | 6,177 | 6,177 | 6,177 | 6,177 |
| End Cash Position | 6,738 | 8,913 | 9,604 | 11,453 | 9,350 |
| Net Cash Flow | $-2,174 | $2,736 | $3,427 | $5,276 | $3,174 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,174 | -7,283 | -6,625 | -4,969 | -2,256 |
| Capital Expenditure | N/A | -160 | -128 | N/A | N/A |
| Free Cash Flow | -2,174 | -7,443 | -6,754 | -4,969 | -2,256 |